Posters

Different therapeutic options of bilateral macular edema. Case report

Poster Details

First Author: M.Musiał Kopiejka POLAND

Co Author(s):    A. Wylegala   A. Lysek Boron   D. Dobrowolski                       

Abstract Details



Purpose:

To report a case of a patient with bilateral macular edema (ME) resulting from retinal vein occlusion.

Setting:

67 year old male, treated for hypertension and myocardial insufficiency, was treated with anti-coagulants (Xarelto) and antihypertensive drugs (Amlodipine).

Methods:

The patient developed BRVO in left eye altogether with macular edema BCVA=0.2, central retinal thickness (CRT) was 341 um. 2 weeks later CRVO with extensive molecular edema=649 µm appeared in the right eye.

Results:

ME in the left eye was successfully treated with Eylea® (Aflibercept), which lead to rise in BCVA=0.5, as well as retinal edema decresed to 269. BCVA in the right eye prior to treatment equalled to hand movements. Patient received locally: dexamethasone and CAI, while orally prescribed medications included Acetazolamide, Prednisone, Sulodexide and Troxerutin. During the follow up visit, we observed an increase in BCVA to =0.6 and CRT=343 um in the right eye. We decided to inject an Eylea®, which lead to an increase of BCVA=0,9 and decrease of CRT=264 um.

Conclusions:

Conclusion: Intravitreal injections of anti-VEGF can successfully lead to a decrease in macular edema resulting from BRVO and CRVO, however good results can also be achieved with the use of topical and systematic drugs.

Back to previous
EURETINA, Temple House, Temple Road, Blackrock, Co Dublin. | Phone: 00353 1 2100092 | Fax: 00353 1 2091112 | Email: euretina@euretina.org

Privacy policyHotel Terms and Conditions Cancellation policy